Humana’s CenterWell pharmacy will dispense GLP-1 weight loss drugs made by Eli Lilly as part of a new program for employers ...

Weight management medications show limited long-term effects, with rapid weight regain post-treatment, emphasizing the need ...

The Obesity Association, a division of the American Diabetes Association (ADA), has issued new standards of care on the ...

Eli Lilly working Humana to distribute obesity medications through employer-focused programs via CenterWell Pharmacy.

CenterWell Pharmacy announced that it will dispense Eli Lilly's obesity drugs within employer weight management programs. | ...

Obstacles to preventing and treating obesity, including limited access to healthy foods, limited time to prepare meals and ...

The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like ...

Learn how GLP-1 medications support weight loss and heart health in perimenopause and postmenopause, plus get tips for ...

A recent study published in JAMA Network Open finds a strong link between prescription trends of obesity management medications and public online search activities in the United States. The study ...

UK experts are warning that access to new weight-loss drugs could depend more on wealth than medical need. Strict NHS ...

Asian and Hispanic individuals had significantly lower odds of utilizing obesity-management medications compared with White individuals. (HealthDay News) — Racial and ethnic disparities are seen in ...

New research calls for routine risk stratification of MASLD in people with obesity to detect and manage liver disease earlier ...